Segantii Capital Management’s Orion Biotech Opportunities Corp. Warrant ORIAW Stock Holding History

Segantii Capital Management’s Portfolio ORIAW Stock Details ORIAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-30,000	Closed	-$307K	–	332
2023 Q1	$307K	Hold	30,000	–	–	0.01%	253
2022 Q4	$302K	Hold	30,000	–	–	0.01%	326
2022 Q3	$295K	Hold	30,000	–	–	0.01%	438
2022 Q2	$292K	Hold	30,000	–	–	0.01%	435
2022 Q1	$292K	Hold	30,000	–	–	0.01%	462
2021 Q4	$290K	Hold	30,000	–	–	0.01%	450
2021 Q3	$295K	Buy	+30,000	New	+$39K	0.01%	380

Segantii Capital Management's ORIAW Position: Q2 2023 in Review

Segantii Capital Management sold out of Orion Biotech Opportunities Corp. Warrant (ORIAW) in Q2 2023, closing a stake of 30,000 shares — an estimated $307K sold.

Segantii Capital Management first reported a position in ORIAW in Q3 2021 and held it in 7 quarters. The position peaked at $307K in Q1 2023. 0 funds tracked by Wall St. Rank hold ORIAW as of Q2 2023.

Segantii Capital Management reported no remaining Orion Biotech Opportunities Corp. Warrant position as of Q2 2023 after selling out during the quarter.
Segantii Capital Management sold 30,000 Orion Biotech Opportunities Corp. Warrant shares in Q2 2023, an estimated $307K.
Segantii Capital Management first reported a position in Orion Biotech Opportunities Corp. Warrant in Q3 2021 and held it in 7 quarters.
Segantii Capital Management's Orion Biotech Opportunities Corp. Warrant position peaked at $307K in Q1 2023.
0 funds tracked by Wall St. Rank held Orion Biotech Opportunities Corp. Warrant as of Q2 2023.

Based on Segantii Capital Management's 13F filing for Q2 2023, filed 2 Aug 2023.